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Objective: The aim of this study was to identify factors influencing the prescribing of 
psychotropic medication by general practitioners (GPs) to nursing home residents with dementia.
Subjects and methods: GPs with experience in nursing homes were recruited through 
professional body newsletter advertising, while 1,000 randomly selected GPs from south-
eastern Australia were invited to participate, along with a targeted group of GPs in Tasmania. 
An anonymous survey was used to collect GPs’ opinions.
Results: A lack of nursing staff and resources was cited as the major barrier to GPs recommend-
ing non-pharmacological techniques for behavioral and psychological symptoms of dementia 
(BPSD; cited by 55%; 78/141), and increasing staff levels at the nursing home ranked as the 
most important factor to reduce the usage of psychotropic agents (cited by 60%; 76/126).
Conclusion: According to GPs, strategies to reduce the reliance on psychotropic medication 
by nursing home residents should be directed toward improved staffing and resources at the 
facilities.
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Impact statement
The findings of this research suggest that, according to general practitioners (GPs), 
reforming the prescribing of psychotropic medication in nursing home residents with 
behavioral and psychological symptoms of dementia is best achieved by increasing the avail-
ability of non-pharmacological, diversional and other behavior modification resources.
Introduction
Behavioral and psychological symptoms of dementia (BPSD) occur in up to 90% of 
patients with dementia over the course of their illness, lead to distress to patients and 
caregivers, and increase health care costs associated with hospitalizations.1
Guidelines routinely suggest non-pharmacological interventions as the first-line 
therapy for BPSD, with certain psychotropic agents, such as antipsychotic medication, 
being second line due to the limited benefit and risk of serious adverse effects.2 The 
use of antipsychotics in these patients has been associated with an increased risk of 
mortality, hip fractures, thrombotic and cardiovascular events, and hospitalizations.3 
Psychosocial approaches are preferred, tailoring them to the needs of the patient and 
creating a physical environment to reduce distress.4
There are concerns that there is a significant gap between guideline recommenda-
tions and practice in nursing home facilities when managing BPSD in Australia.5,6 
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Internationally, similar concerns have also been echoed 
recently.7 The factors involved in prescribing and withdraw-
ing psychotropic agents by general practitioners (GPs) in 
the nursing home setting include GPs having a very low 
willingness to discontinue antipsychotics for fear of wors-
ening symptoms8 and an overexpectation of benefit from 
antipsychotic therapy in BPSD.9 One study found that GPs 
were critical of their knowledge and management in this 
area and suggested that efforts should focus on educational 
interventions for GPs.10 In Australia, however, there are no 
published papers on the barriers to the evidence-based pre-
scribing of psychotropic medication for people with BPSD 
in nursing homes.
We aimed to identify the factors influencing the prescrib-
ing of psychotropic medication to residents of Australian 
nursing homes with BPSD, and therefore determine strategies 
to promote more appropriate use of these medications.
Subjects and methods
Participant recruitment
Three iterative strategies were required to recruit enough 
Australian GPs to ensure an adequate sample size. Initially, 
GPs with experience in patient care in nursing homes were 
recruited through professional body advertising in newsletters 
in the state of Tasmania. This strategy had limited success. 
Next, 1,000 GPs mostly from southeastern Australia were 
randomly selected from an Australian Health Directory and 
mailed, with a follow up email sent to the surgeries with 
listed email addresses. Finally, a targeted group of 273 GPs 
in Tasmania who were known to have patients in nursing 
homes, based on their previous involvement in clinical 
activities, was invited by mail to complete the survey. While 
the GPs in this study were from only two states in Australia, 
their demographics were similar to the wider GP population 
in Australia.11 This study received ethical approval from the 
Tasmanian Social Sciences Human Research Ethics Com-
mittee (ethics reference number H0014615). Consent was 
assumed through completing the survey.
Questionnaire development
The anonymous 26-question survey was self-completed 
through either a paper-based version or an online version 
using Lime Survey.12 Participants were invited to enter a 
prize draw for an electronic device as an incentive.
This original questionnaire was developed from the 
clinical experience of the researchers and the results of 
international research.8–10,13,14 The questionnaire was piloted 
in a small group of GPs and pharmacists and refined based 
on their feedback.
Analysis
The outcomes of interest included GP perception of the 
factors that are most important to reduce psychotropic 
prescribing and barriers to using non-pharmacological 
techniques for BPSD, based on those found in the literature. 
The self-reported prescribing habits in BPSD and expectation 
of benefit were also of interest, with a Likert scale used to 
determine how effective the GPs believed the medication to 
be in practice. The survey relied on the GPs’ definition of 
settled and stabilized patients.
Data were analyzed using SPSS version 22 (IBM 
Corporation, Armonk, NY, USA).15 Chi-square tests were 
used, with a P-value of ,0.05 considered significant. 
Responses to a 5-point Likert-type scale were collapsed into 
two categories. The first category included “rarely to some 
patients,” while the second category included “50% to most 
or all patients,” as given in Table 1. Reponses to ranking 
questions were presented with the top two ranked questions, 
as shown in Figures 1 and 2.
Results
Demographics
In total, 177 responses were returned. The majority (89%; 
158/177) of the respondents were from Victoria and Tasmania, 
with most (61%; 109/177) having been registered as a medi-
cal practitioner for 20–40 years (Table 2). The uptake of 
the survey was probably limited by needing access to GPs 
with the appropriate patients. Response rates were difficult 
Table 1 Prescribing habits
Variable 50% to most 
or all patients
Rarely to 
some patients
Thinking about your patients, what do you believe is the extent 
of positive benefit (such as a reduction in behaviors) for the 
following agents in BPSD?
second-generation antipsychotics 63% (112/177) 36% (63/177)
First-generation antipsychotics 25% (44/177) 70% (125/177)
Benzodiazepines 23% (41/177) 76% (134/177)
Antidepressants 35% (62/177) 65% (113/177)
In the following situations, would you prescribe an 
antipsychotic in dementia?
Physical aggression 63% (111/177) 37% (64/177)
Verbal aggression 32% (56/177) 66% (116/177)
Agitation and unsettled 43% (76/177) 56% (100/177)
Calling out 14% (24/177) 85% (150/177)
Wandering 10% (17/177) 89% (157/177)
In your experience, to what extent do adverse effects from the 
following agents limit their prescribing in BPSD?
second-generation antipsychotics 32% (56/177) 68% (121/177)
First-generation antipsychotics 65% (112/177) 35% (59/177)
Benzodiazepines 54% (96/177) 45% (79/177)
Antidepressants 23% (40/177) 77% (136/177)
Abbreviation: BPsD, behavioral and psychological symptoms of dementia.
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to calculate, with an unknown number of GPs ineligible to 
complete the survey because they did not have nursing home 
patients under their care at the time of the study. Of the 
1,000 randomly selected GPs, it is expected that approximately 
half would have been eligible to complete the survey, based 
on a 2015/16 survey indicating 49% of GPs have provided 
care in a residential aged care facility in the previous 
month.16 This suggests that a response rate of ~21% was 
Figure 1 Barriers to non-pharmacological management of BPsD.
Abbreviation: BPsD, behavioral and psychological symptoms of dementia.
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???????????????????????????????????????????????
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Figure 2 What would help reduce the usage of psychotropic agents in BPsD?
Abbreviations: BPsD, behavioral and psychological symptoms of dementia; gPs, general practitioners.
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achieved (105/490). For the 273 Tasmanian GPs known 
to have residents in nursing homes, the response rate was 
23% (64/273).
Barriers to non-pharmacological 
interventions and psychotropic 
medication reduction
“Aged care facility staffing and resources” was clearly 
highlighted as the number 1 barrier to non-pharmacological 
methods being utilized in BPSD. Likewise, directing funding 
to adequately staff facilities was the preference to reduce 
psychotropic usage in aged care (Figures 1 and 2).
Prescribing habits
Responses to selected questions concerning prescribing 
habits are given in Table 1. The vast majority expressed 
a desire to reduce psychotropic medication in completely 
settled or stabilized patients. When asked what they would 
do if a patient had been taking an antipsychotic for 6 months 
with no ongoing difficulties, 76% (135/177) indicated they 
would reduce the dosage of an antipsychotic with a view 
to cessation if possible. Similarly, when asked about ben-
zodiazepine prescribing for BPSD in settled patients, 90% 
(159/176) indicated they would be likely to reduce or cease 
the benzodiazepine.
Management of BPsD
When asked if they routinely recommend non-pharmacological 
interventions before considering medication in BPSD, 
81% (144/177) agreed or strongly agreed. About half (47%; 
84/177) agreed that they feel they require more training 
to improve how they manage BPSD, with 24% (42/177) 
disagreeing.
The majority of respondents, 71% (126/177), indicated 
that they review their aged care residents’ medication three-
monthly or more often, with 19% (34/177) reviewing the 
medication six-monthly, and the remainder annually or less.
Influences on prescribing for BPSD 
in nursing homes
Most GPs indicated that nurses (91%; 160/177) and family 
of residents (59%; 105/177) influence their prescribing. 
Interestingly, only one-third (33%; 58/177) indicated that 
nurses have requested psychotropic dose reductions and 
about the same from family (36%; 64/177). The majority 
of GPs (81%; 143/177) reported having had to decline a 
request from family or staff to prescribe an antipsychotic, 
with 39% (69/177) having to regularly refuse. Experienced 
GPs (20–40 years of experience) were significantly less likely 
(5%; 9/109) to rate pressure to prescribe from aged care facil-
ity staff as a barrier to non-pharmacological techniques than 
GP practising ,5 years (29%; 5/17). Pharmacists were cited 
as the most likely health profession to request dose reductions 
(51%; 91/177); however, they were stated to only influence 
the actual prescribing by 28% (50/177). Over half of GPs 
(56%; 100/177) were confident that pharmacist-conducted 
residential medication management reviews (RMMRs) are 
beneficial in BPSD management, with a further 25% (44/177) 
who were unsure.
Concern for a reduced quality of life when withdrawing 
psychotropic agents received a mixed response, with 42% 
(75/177) agreeing they were concerned that withdrawing 
medication would impact negatively on the quality of 
life, leading to a return of challenging behaviors and 
disturbing psychological symptoms. About the same number 
(41%; 73/177) disagreed with this statement.
Confidence to reduce dosing after a failed first attempt 
was quite variable, with 35% (62/177) stating they did not 
feel confident to trial a second dose reduction, 23% (41/177) 
were undecided, and 42% (74/177) feeling confident to trial 
a second reduction attempt.
Discussion
Our findings imply that reforming the prescribing of antipsy-
chotic medication in nursing homes is best targeted toward 
staffing levels and increasing the availability of diversional 
and other behavior modification resources. Similarly, a study 
from the Netherlands found staffing issues as a factor related 
to psychotropic drug prescribing.17
In this study, increasing funding to GPs was not shown as 
priority to reduce psychotropic prescribing in nursing homes. 
This contrasts with other studies into servicing nursing 
homes in Australia18 and the USA13 which found that levels 
of reimbursement and time were important barriers to GPs 
providing a range of services in this setting. It is possible 
that in our study GPs perceived that increased funding to 
Table 2 Demographics
Variable Percentage/number
Total number of responses 177
Female 43% (76/175)
Male 57% (99/175)
Length of time registered as a medical practitioner
For ,5 years 10% (17/177)
For 6–10 years 6% (10/177)
For 11–20 years 15% (27/177)
For 20–40 years 62% (109/177)
For $40 years 8% (14/177)
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them would not improve access to behavioral and support 
therapies in dementia care as they are not fund holders for 
these services.
GPs in our study, and similarly in a Dutch study,9 over-
estimated the benefit in symptom relief of second-generation 
antipsychotics compared with symptom outcomes in field 
studies19 and therapeutic guidelines,2 with 63% of GPs 
expecting benefit in half of all patients. The number needed 
to treat for second-generation antipsychotics in dementia 
is expected to be 5–14.19 This overexpectation of benefit, 
as given in Table 1, could be contributing to overusage. 
Better dissemination of practice guidelines cautioning 
about the limited benefit of antipsychotic medication in 
BPSD may prompt practitioners to more rationally prescribe 
these medications.
The preference for more training was expressed by around 
half of the respondents in our study. An educational solution 
to this problem is also supported by research from Ireland 
which found that efforts should focus on supporting GPs 
by means of educational interventions and health services 
promoting collaboration.10
Our research found a strong willingness, in principle, to 
reduce psychotropic medication in BPSD with, for example, 
two-thirds of GPs being confident to try a second reduction 
attempt after a failed attempt. Concern about a negative 
impact on the quality of life after drug withdrawal was evenly 
split among respondents. This contrasts to a study from 
Belgium, which found GPs resistant to reduce antipsychotic 
medication, including after a failed attempt, and their concern 
for a negative effect on the quality of life are a large barrier 
to discontinuation of antipsychotics.8
Our results suggest that nursing staff have the largest 
influence on prescribing psychotropic medication in this 
setting, indicating the importance of nursing home staffing 
and resources for non-pharmacological interventions. This is 
consistent with suggestions that any reforms to improve the 
treatment of mental illness and BPSD in nursing homes will 
need to begin with considering the physical design, staffing, 
and skills of staff within nursing homes.20 A Senate inquiry 
into the care of Australians living with dementia and BPSD 
in 2014 heard that staffing levels and training are inadequate, 
with no legislated staffing ratios in nursing homes.21 Stake-
holders reported that restraints are being used too readily 
to cover staff and resourcing limitations. In the inquiry, the 
Australian Medical Association (AMA) indicated that, with 
under-resourced aged care facilities and limited qualified 
nursing staff and sufficient numbers of carers, the need for 
restraint is an unfortunate reality.
Research internationally is mixed in relation to staff 
numbers and qualifications, and the quality of nursing homes 
in general. A systematic review found that focusing on the 
numbers of nurses fails to address the influence of other 
staffing factors, including training and care organization, 
with quality being a difficult concept to capture.22 It goes 
on to state that further research is needed to determine the 
most cost-effective manner to utilize the combination of 
nursing skill levels. Another study found that there was no 
association with caregiver professional training and the care 
given, with a complex relationship between staffing and the 
quality of care provided.23 While our study demonstrates 
the perceived need for increased staffing and resources at 
the facility, further research is required to determine the best 
models for the delivery of cost-effective and efficient non-
pharmacological interventions in BPSD. This dementia care 
redesign in nursing homes could be informed by Effective 
Practice and Organization of Care (EPOC) methodology.24 
Repeating a similar survey in nursing staff to assess their 
experiences would also be worthwhile to help determine 
whether these perceptions are shared across professions.
Limitations of this study include the relatively small 
sample size and the apparent low response rate. A further 
limitation is relying on the GPs’ recall of what they would 
prescribe or withdraw in certain situations. This limitation 
is likely to bias the responses toward the perceived best 
practice; however, it will provide an idea of what the GPs 
would like to do if there were no barriers to this practice. 
Although the questionnaire was not validated, it was sampled 
in a small number of GPs before use and refined based on 
their feedback. In addition, the types and severity of dementia 
did not form part of the survey.
Conclusion
GPs described inadequate nursing staff levels and resources 
as the main factors that limit the use of non-pharmacological 
interventions and their ability to reduce the usage of psycho-
tropic agents in nursing homes.
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